IBOV 172,236.05 ▲ 2.22% IPC MEX 72,104.80 ▲ 1.00% MERVAL 2,848,945 — — USD/BRL5.51▲ 0.04% USD/MXN18.52▼ 0.59% USD/CLP966.96▼ 0.99% USD/COP3,269▲ 0.88% USD/PEN3.41▼ 1.07% USD/ARS1,545▼ 0.02% USD/UYU40.45▲ 0.35% USD/PYG6,450▲ 1.45% USD/BOB11.74▼ 0.59% USD/DOP60.46▼ 0.21% USD/CRC446.56▼ 0.38% USD/GTQ7.64▼ 0.05% USD/HNL26.89▲ 0.02% USD/NIO 36.62 — 0.00% USD/VES897.02▲ 0.07% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.79▼ 0.02% USD/TTD6.72▼ 0.03% EUR/BRL6.18▲ 0.85% BRENT 91.60 ▼ 1.05% WTI 85.80 ▼ 1.21% IRON ORE 161.91 — — COPPER 6.34 ▲ 0.14% GOLD 4,121 ▲ 0.16% SILVER 53.00 ▲ 0.83% SOY 1,189 ▲ 0.59% CORN 440.25 ▲ 0.23% WHEAT 588.50 ▲ 0.09% COFFEE 266.70 ▼ 4.75% SUGAR 18.21 ▼ 0.16% ORANGE JUICE 143.50 ▲ 7.85% COTTON 78.65 ▼ 0.58% COCOA 5,113 ▼ 0.81% BEEF 216.33 ▲ 1.06% CATTLE 324.80 ▲ 0.77% LITHIUM 61.35 ▲ 0.72% PETR4 45.19 ▼ 0.24% VALE3 66.11 ▲ 3.23% ITUB4 41.72 ▲ 2.94% BBDC4 14.68 ▲ 3.38% ABEV3 15.61 ▲ 0.84% BBAS3 17.02 ▼ 0.64% B3SA3 14.85 ▲ 3.20% WEGE3 50.74 ▲ 5.29% PRIO3 59.39 ▼ 1.80% SUZB3 54.20 ▲ 1.50% RENT3 30.83 ▲ 1.78% AZZA3 15.12 ▲ 2.44% CSAN3 2.77 — 0.00% RAIZ4 28.00 ▲ 2.56% PCAR3 2.43 ▲ 1.25% GMAT3 3.83 ▲ 0.79% PSSA3 45.65 ▲ 2.93% CVCB3 0.87 ▲ 3.57% POSI3 3.03 ▼ 1.94% SLCE3 17.30 ▲ 4.15% NATU3 5.71 ▲ 10.44% BRKM5 3.02 ▼ 5.63% RANI3 8.76 ▲ 3.44% CSNA3 4.49 ▲ 1.81% IBOV 172,236.05 ▲ 2.22% IPC MEX 72,104.80 ▲ 1.00% MERVAL 2,848,945 — — USD/BRL 5.51 ▲ 0.04% USD/MXN 18.52 ▼ 0.57% USD/CLP 966.96 ▼ 0.99% USD/COP 3,269 ▲ 0.88% USD/PEN 3.41 ▼ 1.07% USD/ARS 1,545 ▼ 0.02% USD/UYU 40.45 ▲ 0.35% USD/PYG 6,450 ▲ 1.45% USD/BOB 11.74 ▼ 0.59% USD/DOP 60.46 ▼ 0.21% USD/CRC 446.56 ▼ 0.38% USD/GTQ 7.64 ▼ 0.05% USD/HNL 26.89 ▲ 0.02% USD/NIO 36.62 — 0.00% USD/VES 897.02 ▲ 0.07% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.79 ▲ 2.42% USD/TTD 6.72 ▲ 2.10% EUR/BRL 6.18 ▲ 0.85% BRENT 91.60 ▼ 1.05% WTI 85.80 ▼ 1.21% IRON ORE 161.91 — — COPPER 6.34 ▲ 0.14% GOLD 4,121 ▲ 0.16% SILVER 53.00 ▲ 0.83% SOY 1,189 ▲ 0.59% CORN 440.25 ▲ 0.23% WHEAT 588.50 ▲ 0.09% COFFEE 266.70 ▼ 4.75% SUGAR 18.21 ▼ 0.16% ORANGE JUICE 143.50 ▲ 7.85% COTTON 78.65 ▼ 0.58% COCOA 5,113 ▼ 0.81% BEEF 216.33 ▲ 1.06% CATTLE 324.80 ▲ 0.77% LITHIUM 61.35 ▲ 0.72% PETR4 45.19 ▼ 0.24% VALE3 66.11 ▲ 3.23% ITUB4 41.72 ▲ 2.94% BBDC4 14.68 ▲ 3.38% ABEV3 15.61 ▲ 0.84% BBAS3 17.02 ▼ 0.64% B3SA3 14.85 ▲ 3.20% WEGE3 50.74 ▲ 5.29% PRIO3 59.39 ▼ 1.80% SUZB3 54.20 ▲ 1.50% RENT3 30.83 ▲ 1.78% AZZA3 15.12 ▲ 2.44% CSAN3 2.77 — 0.00% RAIZ4 28.00 ▲ 2.56% PCAR3 2.43 ▲ 1.25% GMAT3 3.83 ▲ 0.79% PSSA3 45.65 ▲ 2.93% CVCB3 0.87 ▲ 3.57% POSI3 3.03 ▼ 1.94% SLCE3 17.30 ▲ 4.15% NATU3 5.71 ▲ 10.44% BRKM5 3.02 ▼ 5.63% RANI3 8.76 ▲ 3.44% CSNA3 4.49 ▲ 1.81%
since 2009
Tuesday, November 10, 2026

Covid-19 Brazil

Brazil’s ex-Minister of Health Pazuello refuses to appear before Senate CPI on Covid-19

By · · 2 min read

RIO DE JANEIRO, BRAZIL – General Eduardo Pazuello, Brazil’s ex-minister of Health and whose management of the pandemic is under investigation by Justice, on Tuesday, May 5, announced that he will not appear before the Parliamentary Inquiry Committee (CPI) because he had contact with people with Covid-19.

“Ex-minister Pazuello says that this weekend he had contact with two colonels who have Covid,” explained Senator Otto Aziz, the committee’s chair, when announcing Pazuello’s failure to appear this Wednesday, as planned.

General Eduardo Pazuello
General Eduardo Pazuello.
RT
Ask Rio Times
This story and the bigger picture.
Open the full Ask Rio Times →

Aziz said that the committee will decide later when Pazuello’s testimony will be taken, which according to the CPI rules must be in person, although it could be possible to do it remotely.

The committee was created under pressure from the opposition and aims to investigate alleged omissions in the measures implemented by Jair Bolsonaro’s government to tackle the coronavirus. Bolsonaro heads a denialist ultra-right-wing that even today downplays the impact of a pandemic that has killed almost 410,000 people in the country.

Pazuello, a general specialized in logistics but with no previous experience in the health area, was appointed Minister of Health in May last year and remained in the post until last month, when he was dismissed due to pressure from sectors close to the government and Congress.

The general, who authorized the use of drugs in public hospitals with no proven efficacy against Covid-19, allegedly dragged his feet in the purchase of vaccines and criticized the use of masks and social distancing measuresç he is being investigated in the courts for alleged omissions that the Senate committee is trying to clarify.

Pazuello’s statement before the parliamentary committee is viewed with concern by the government, because, unlike the courts, this group is much more political in nature and is mainly made up of opposition senators.

This Tuesday, the committee will hear also ex-minister of Health Luiz Henrique Mandetta, who was in office when the pandemic emerged in Brazil, in February 2020, and was dismissed in April that same year for his strong support for quarantines to contain the contagions, a measure that Bolsonaro rejects to this day.

In addition to Mandetta, his successor, oncologist Nelson Teich, who resigned after disagreements with Bolsonaro over the use of chloroquine and other drugs of dubious efficacy that the president also still promotes, has also been summoned to testify.

The current Minister of Health, Marcelo Queiroga, a cardiologist who succeeded Pazuello, will also be required to testify.

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.